Cindy M. Pabon, MD
@cmpabon
Followers
942
Following
6K
Media
97
Statuses
611
Assistant prof @SylvesterCancer focused on gastric & esophageal cancer | Trained @MDAndersonNews @IMResidencyDuke & @UFMedicine | Wife & Mom | Go gators! š
Miami, FL
Joined January 2020
In 2018 I shared a message on advocacy as physicians. As the depth of #StructuralRacism in our country is further revealed by the devastating loss of #GeorgeFloyd and disparities within #COVID19, I challenge you to stand up for your community #MedTwitter
floridaphysician.med.ufl.edu
Adapted from the 2018 UF College of Medicine Commencement Ceremony speech by graduate Dr. Cindy Medina Pabon.
3
8
64
RT @KoheiShitara: Pleased to report FGFR2b expression in gastric cancer and relationship with other biomarkers @ESMO_Open @myESMO. The resā¦.
0
24
0
Who says working on your birthday canāt be fun?! Loved spending it with my @SylvesterCancer team š¤
1
1
19
RT @jessiemac07: Great presentation by @PeterHoseinMD from @SylvesterCancer on pancreas subtypes. Nice to see progress in pancreatic cancerā¦.
0
5
0
RT @SylvesterCancer: Our very own Dr. Peter Hosein (@PeterHoseinMD) presented "Is Pancreas Subtyping Ready for Prime Time?" at #ASCO25 in aā¦.
0
13
0
RT @HemOncMiami: Join tomorrow morning at 9 AM to learn about #pancreaticcancer subtyping, biomarkers and vaccine research @PeterHoseinMD @ā¦.
0
3
0
RT @GlopesMd: Have you signed up for #MiamiNights yet? . @SylvesterCancer @asco #asco25 . We are hiring - Looking for chiefs for breast andā¦.
0
7
0
RT @SylvesterCancer: Stomach cancer is tough to detect early and often diagnosed late. Sylvester experts are tackling it through preventionā¦.
0
3
0
RT @NarjustFlorezMD: Here is the thing friendsā¦. She went for it!. I am running for the @IASLC Board of Directors because I believe in theā¦.
0
24
0
RT @COlazagasti: This study was born from personal experiences and nostalgia. We hoped that these findings would provoke conversations andā¦.
0
6
0
RT @caitlinahester: A shameless, non-self-promoting post for my absolute rockstar partner, @DrJashDatta. He made a compelling argument in fā¦.
0
3
0
RT @SylvesterCancer: Is there anything in your diet that can increase the chances of developing #stomach #cancer? Tune in as Dr. Cindy Paboā¦.
0
3
0
RT @NorthwellHealth: Did you know that colorectal cancer is one of the most preventable cancers, yet it's still a leading cause of cancer dā¦.
0
5
0
RT @OncJournal: In this review, @cmpabon et al summarize recent data on the optimal preoperative strategy for esophageal or gastro-esophageā¦.
0
1
0
RT @MichaelLaPelusa: Always great to learn new data in SF and connect with mentors + friends @ASCO GI. Thanks to @ConquerCancerFd for the Mā¦.
0
13
0
RT @KrishanJethwa: š„NRG GI-007š„. LA-Esophagus Carcinoma.š dCRT (50.4 Gy/28 fx carbo/taxol) + endoscopically injected oncolytic virus OBP-3ā¦.
0
47
0
RT @KellyMezaMD: #ASCOGI2025 Presenting our poster on #biomarkers of response to FGFR inhibitors on patients with #cholangiocarcinoma @MDAnā¦.
0
4
0
#GI25 Anna Dorothea Wagner presents EORTC-1203 GITC "INNOVATION": Integration of trastuzumab +/- pertuzumab into perioperative chemo in HER2+ GC. Adding HER-2 agents improves mpRR but didn't result in OS benefit when amended to group with SOC FLOT. Tx with noted toxicities.
0
0
1
#GI25 Xuefeng Leng presents neoadjuvant chemoRT +/- sintilimab for ESCC. Statistically significant improvement in pCR rates. but is this similar to the reduction in disease we see with CHECKMATE-577? Will need long term survival data for both studies to see if sequence matters.
0
0
4